A recent mechanistic study using LDL receptordeficient mice and ox-LDLchallenged human endothelial cells demonstrated that liraglutide, one of the most widely studied GLP-1RAs, directly improves endothelial function by suppressing oxidative and inflammatory pathways ( in vitro experiments showed that liraglutide mitigated oxLDL-induced endothelial injury by suppressing NOX4 and NF-B signaling, and downregulating ICAM-1 and VCAM-1 expression ( 2.3 GLP-1RA modulation of promotion cholesterol efflux Beyond inflammation, impaired cholesterol efflux from macrophage-derived foam cells, mediated by key transporters such as ABCA1 and ABCG1, contributes to intracellular lipid accumulation and promotes plaque progression and instability ( A study in 2022 demonstrated that targeted GLP-1RA nanoparticles directly reduced vascular inflammation in ApoE/ mice, even at doses too low to affect glycemia or body weight ( Tnf and Icam1 expression with a concomitant increase in Arg1 , a marker of alternative macrophage activation

See my next article on this topicsweets and snacking between meals is the Achilles Heel of these miracle weight loss drugs and the number one reason they wont work
Alex Sinclair , a neurologist at the University of Birmingham in the U.K
The First Marketed Peptibody Romiplostim (Nplate) is a peptibody, a fusion protein-thrombopoietin (THPO) peptide mimetic
As your body reaches a new metabolic equilibrium and you adjust your caloric intake upward slightly once weight loss stabilizes, cold intolerance diminishes